B
BGT
BIO-GENE TECHNOLOGY
0.031
-0.001-3.13%Opening15:10 04/08 AEST
OPEN/PREV CLOSE0.032/0.032
TODAY RANGE0.031-0.032
VOL66.09K
MARKET CAP9.46M
52 WEEK RANGE0.016-0.061
AVG VOL (3M)161.25K
% TURNOVER0.02%
TURNOVER2.22K
P/E (TTM)-3.2292
% RANGE3.13%
EPS(TTM)-0.0096
P/E(FORWARD)1.033
P/B8.16
BVPS0.0038
DIVIDEND--
P/S19.38
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.19M
SHARES OUTSTANDING305.06M
NEXT EARNINGS07/29-08/03
FREE FLOAT135.08M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·03/26 01:22
NWR Healthcare Conference Presentation
ASX·03/19 23:00
Bio-Gene to present at NWR Healthcare Conference
ASX·03/15 21:20
Sumitomo & Nakashima to launch Qcide products in Japan
ASX·03/09 22:30
Update on Qcide Production
ASX·03/02 22:07
Regulatory Development of Flavocide
ASX·02/23 22:37
Appendix 4D and Half-Year Accounts 31 December 2025
ASX·02/12 22:47
Flavocide Acute Neurotoxicity Study Underway
ASX·02/08 22:34
Flavocide Reproductive Toxicity Study Underway
ASX·02/01 22:12
CFO and Company Secretary Appointment/Resignation
ASX·01/29 21:26
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·12/17/2025 21:55
U.S. Department of Defense Grant Programs Advance
ASX·12/01/2025 21:24
Outcome of review of Continuous Disclosure Procedures
ASX·11/24/2025 21:18
Bio-Gene Receives $519,500 R&D Tax Incentive
ASX·11/18/2025 22:43
Results of Meeting
ASX·11/18/2025 21:23
CEO's Presentation
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others